185 related articles for article (PubMed ID: 37277368)
1. The dynamics of telomere length in primary and metastatic colorectal cancer lesions.
Kroupa M; Kubecek O; Tomasova K; Hanak P; Krupova M; Cervena K; Siskova A; Rosendorf J; Hosek P; Vodickova L; Vodicka P; Liska V; John S; Vymetalkova V; Petera J
Sci Rep; 2023 Jun; 13(1):9097. PubMed ID: 37277368
[TBL] [Abstract][Full Text] [Related]
2. Relationship of telomere length in colorectal cancer patients with cancer phenotype and patient prognosis.
Kroupa M; Rachakonda SK; Liska V; Srinivas N; Urbanova M; Jiraskova K; Schneiderova M; Vycital O; Vymetalkova V; Vodickova L; Kumar R; Vodicka P
Br J Cancer; 2019 Aug; 121(4):344-350. PubMed ID: 31312029
[TBL] [Abstract][Full Text] [Related]
3. Relationship between telomere shortening, genetic instability, and site of tumour origin in colorectal cancers.
Rampazzo E; Bertorelle R; Serra L; Terrin L; Candiotto C; Pucciarelli S; Del Bianco P; Nitti D; De Rossi A
Br J Cancer; 2010 Apr; 102(8):1300-5. PubMed ID: 20386541
[TBL] [Abstract][Full Text] [Related]
4. Clinical Relevance of Telomere Status and Telomerase Activity in Colorectal Cancer.
Fernández-Marcelo T; Sánchez-Pernaute A; Pascua I; De Juan C; Head J; Torres-García AJ; Iniesta P
PLoS One; 2016; 11(2):e0149626. PubMed ID: 26913901
[TBL] [Abstract][Full Text] [Related]
5. Telomere length is a novel predictive biomarker of sensitivity to anti-EGFR therapy in metastatic colorectal cancer.
Augustine TA; Baig M; Sood A; Budagov T; Atzmon G; Mariadason JM; Aparo S; Maitra R; Goel S
Br J Cancer; 2015 Jan; 112(2):313-8. PubMed ID: 25412235
[TBL] [Abstract][Full Text] [Related]
6. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Engelhardt M; Drullinsky P; Guillem J; Moore MA
Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
[TBL] [Abstract][Full Text] [Related]
7. Shorter leukocyte telomere length is independently associated with poor survival in patients with bladder cancer.
Russo A; Modica F; Guarrera S; Fiorito G; Pardini B; Viberti C; Allione A; Critelli R; Bosio A; Casetta G; Cucchiarale G; Destefanis P; Gontero P; Rolle L; Zitella A; Fontana D; Frea B; Vineis P; Sacerdote C; Matullo G
Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2439-46. PubMed ID: 25234236
[TBL] [Abstract][Full Text] [Related]
8. Reduced telomere length in colorectal carcinomas.
Feng TB; Cai LM; Qian KQ; Qi CJ
Asian Pac J Cancer Prev; 2012; 13(2):443-6. PubMed ID: 22524803
[TBL] [Abstract][Full Text] [Related]
9. [Accelerated telomere erosion in schizophrenia: A literature review].
Corfdir C; Pignon B; Szöke A; Schürhoff F
Encephale; 2021 Aug; 47(4):369-375. PubMed ID: 33863507
[TBL] [Abstract][Full Text] [Related]
10. Telomere Length, TERT, and miRNA Expression.
Slattery ML; Herrick JS; Pellatt AJ; Wolff RK; Mullany LE
PLoS One; 2016; 11(9):e0162077. PubMed ID: 27627813
[TBL] [Abstract][Full Text] [Related]
11. Influence of primary site on metastatic distribution and survival in stage IV colorectal cancer.
Suthananthan AE; Bhandari M; Platell C
ANZ J Surg; 2018 May; 88(5):445-449. PubMed ID: 28512795
[TBL] [Abstract][Full Text] [Related]
12. Pre-diagnostic telomere length and colorectal cancer risk.
Yang K; Prescott J; Hazra A; Meyerhardt JA; Zhang X; De Vivo I; Chan AT; Du M; Giovannucci EL; Nan H
Cancer Epidemiol; 2022 Apr; 77():102100. PubMed ID: 35033923
[TBL] [Abstract][Full Text] [Related]
13. The presence of telomere fusion in sporadic colon cancer independently of disease stage, TP53/KRAS mutation status, mean telomere length, and telomerase activity.
Tanaka H; Beam MJ; Caruana K
Neoplasia; 2014 Oct; 16(10):814-23. PubMed ID: 25379018
[TBL] [Abstract][Full Text] [Related]
14. The relationship between telomere length and clinicopathologic characteristics in colorectal cancers among Tunisian patients.
Mzahma R; Kharrat M; Fetiriche F; Bouasker ; Ben Moussa M; Ben Safta Z; Dziri C; Zaouche A; Chaabouni-Bouhamed H
Tumour Biol; 2015 Nov; 36(11):8703-13. PubMed ID: 26047604
[TBL] [Abstract][Full Text] [Related]
15. Telomere length alterations in microsatellite stable colorectal cancer and association with the immune response.
Lopez-Doriga A; Valle L; Alonso MH; Aussó S; Closa A; Sanjuan X; Barquero D; Rodríguez-Moranta F; Sanz-Pamplona R; Moreno V
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2992-3000. PubMed ID: 29908233
[TBL] [Abstract][Full Text] [Related]
16. Dicer and miRNA in relation to clinicopathological variables in colorectal cancer patients.
Stratmann J; Wang CJ; Gnosa S; Wallin A; Hinselwood D; Sun XF; Zhang H
BMC Cancer; 2011 Aug; 11():345. PubMed ID: 21827717
[TBL] [Abstract][Full Text] [Related]
17. Treatment of metachronous colorectal cancer metastases in the Netherlands: A population-based study.
Meyer Y; Olthof PB; Grünhagen DJ; de Hingh I; de Wilt JHW; Verhoef C; Elferink MAG
Eur J Surg Oncol; 2022 May; 48(5):1104-1109. PubMed ID: 34895970
[TBL] [Abstract][Full Text] [Related]
18. Short telomere length and its correlation with gene mutations in myelodysplastic syndrome.
Hwang SM; Kim SY; Kim JA; Park HS; Park SN; Im K; Kim K; Kim SM; Lee DS
J Hematol Oncol; 2016 Jul; 9(1):62. PubMed ID: 27465399
[TBL] [Abstract][Full Text] [Related]
19. Colorectal cancer liver metastases - a population-based study on incidence, management and survival.
Engstrand J; Nilsson H; Strömberg C; Jonas E; Freedman J
BMC Cancer; 2018 Jan; 18(1):78. PubMed ID: 29334918
[TBL] [Abstract][Full Text] [Related]
20. [Liver metastases from colon and rectal cancer in terms of differences in their clinical parameters].
Liška V; Emingr M; Skála M; Pálek R; Troup O; Novák P; Vyčítal O; Skalický T; Třeška V
Rozhl Chir; 2016 Feb; 95(2):69-77. PubMed ID: 27008168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
